Nanobiotix (NBTX) Non-Current Debt (2018 - 2025)

Nanobiotix's Non-Current Debt history runs 8 years deep, the most recent figure standing at $105.9 million for Q4 2025.

• On a quarterly basis, Non-Current Debt rose 115.62% year-over-year to $105.9 million in Q4 2025; TTM through Dec 2025 was $105.9 million, a 115.62% increase from a year earlier, with the FY2025 full-year figure at $102.8 million, up 109.28% from the prior year.
• Non-Current Debt improved to $105.9 million in Q4 2025 per NBTX's latest filing, from $52.6 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $105.9 million in Q4 2025 and bottomed at $28.1 million in Q4 2022.
• The 5-year median for Non-Current Debt is $48.5 million (2023), against an average of $51.5 million.
• Across the five-year window, Non-Current Debt tumbled 35.14% in 2022 and surged 115.62% in 2025, its largest moves.
• Year by year, Non-Current Debt stood at $43.3 million in 2021, then slumped by 35.14% to $28.1 million in 2022, then surged by 74.65% to $49.0 million in 2023, then rose by 0.27% to $49.1 million in 2024, then jumped by 115.62% to $105.9 million in 2025.
• Per Business Quant, the three latest NBTX Non-Current Debt figures stand at $105.9 million (Q4 2025), $52.6 million (Q2 2025), and $49.1 million (Q4 2024).